| Number of patients | Mass type | Median age (IQR) | Postmenopausal (%) | Malignant (%) | Malignant, median age (IQR) |
---|---|---|---|---|---|---|
First cohort (239 women) | 93 | Solid | 56 (21) | 58 (62.4%) | 57 (61.3%) | 51 (20) |
67 | Liquid | 51 (22) | 36 (53.7%) | 12 (17.9%) | 54 (19) | |
79 | Mixed | 58 (23) | 54 (68.4%) | 54 (68.4%) | 58 (21) |